Bioray Biotech Co., Ltd (TPEX:7561)

Bioray Biotech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	207.17	222.73	201.71	191.83	190.6	148.02
Revenue Growth	-6.99%	10.42%	5.15%	0.65%	28.77%	-5.30%
Gross Profit Gross Profit Growth	84.85	105.94	79.03	77.65	80.51	67.29
Operating Income Operating Income Growth	20.18	37.9	-4.32	-19.33	-0.31	-8.11
Net Income Net Income Growth	19.18	32.25	1	-11.56	0.5	-7.19
Earnings Per Share EPS Growth	0.65	1.09	0.03	-0.38	0.02	-0.27
EPS Growth	-40.28%	3533.33%	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	109.21	204.92	178.21	97.02	139.07	126.31
Total Debt Total Debt Growth	70.98	46.29	85.78	69.79	100.91	53.43
Net Cash (Debt) Net Cash Growth	38.23	158.63	92.43	27.23	38.16	72.88
Net Cash Growth	-75.90%	71.62%	239.42%	-28.63%	-47.65%	-13.57%
Net Cash Per Share Net Cash Per Share Growth	1.30	5.36	3.10	0.91	1.36	2.72

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	63.85	71.64	16.65	-0.76	2.48	8.83
Capital Expenditures CapEx Growth	-0.23	-0.37	-3.22	-10.02	-59.64	-14.98
Free Cash Flow Free Cash Flow Growth	63.63	71.27	13.43	-10.78	-57.16	-6.15
Free Cash Flow Growth	-10.72%	430.67%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	40.96%	47.56%	39.18%	40.48%	42.24%	45.46%
Operating Margin	9.74%	17.02%	-2.14%	-10.08%	-0.16%	-5.48%
Pretax Margin	11.84%	18.52%	0.68%	-7.40%	0.36%	-4.17%
Profit Margin	9.26%	14.48%	0.50%	-6.03%	0.26%	-4.86%
FCF Margin	30.71%	32.00%	6.66%	-5.62%	-29.99%	-4.15%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Dividend Per Share Dividend Per Share Growth	0.950	0.950	-	-	0.200
Dividend Per Share Growth	0%	-	-	-	-
Dividend Yield	5.56%	4.54%	-	-	0.67%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	15.69	19.17	634.18	-	1802.11	-
P/FCF Ratio	7.10	8.68	47.32	-	-	-
PS Ratio	2.27	2.78	3.15	4.85	4.73	8.72

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error